Table 1 Baseline characteristics of 26 converted HCC patients
Characteristics | Patients (n=26) |
|---|---|
Median age, years (range) | 56.4 (28~76) |
Age, years, n (%) | |
＜65 | 19 (73.1) |
≥65 | 7 (26.9) |
Sex, n (%) | |
Female | 4 (15.4) |
Male | 22 (84.6) |
ECOG PS, n (%) | |
0 | 10 (38.5) |
1 | 15 (57.7) |
2 | 1 (3.8) |
Hepatitis B virus infection, n (%) | 26 (100) |
Serum AFP level, n (%) | |
<400ng/ml | 10 (38.5) |
400-1000ng/ml | 1 (3.8) |
≥1000ng/ml | 15 (57.7) |
Tumor number, n (%) | |
Solitary | 16 (61.5) |
Multiple | 10 (38.5) |
Tumor size, n (%) | |
＜10cm | 12 (46.2) |
≥10cm | 14 (53.8) |
Child-Pugh classification, n (%) | |
A | 25 (96.2) |
B | 1 (3.8) |
BCLC staging, n (%) | |
A | 6 (23.1) |
B | 1 (3.8) |
C | 19 (73.1) |
CNLC staging, n (%) | |
I | 6 (23.1) |
II | 1 (3.8) |
III | 19 (73.1) |
Liver cirrhosis, n (%) | 21 (80.8) |
Hilar lymphatic metastasis, n (%) | 3 (11.5) |
Intrahepatic metastasis, n (%) | 2 (7.7) |
Extrahepatic metastasis, n (%) | 2 (7.7) |
Reasons of unresectability, n (%) | |
Vp2 | 1 (3.8) |
Vp3 | 10 (38.5) |
Vp4 | 3 (11.5) |
Vv2 | 1 (3.8) |
Vv3 | 4 (15.4) |
Insufficient FLR | 11 (42.3) |
EHM | 5 (19.2) |